We are live on ! Find out more

Drug Manufacturers - Specialty & Generic
Stocks Ranked by
Market Capitalization

Name Market cap Price Price
change %
TAK icon
1
Takeda Pharmaceutical
TAK
$69.3B
$69.3B $21.69 0.46%
TEVA icon
2
Teva Pharmaceutical Industries
TEVA
$49.2B
$49.2B $42.19 0.89%
HLN icon
3
Haleon
HLN
$40B
$40B $9.12 0.87%
ZTS icon
4
Zoetis
ZTS
$34B
$34B $83.72 0.79%
UTHR icon
5
United Therapeutics
UTHR
$24.6B
$24.6B $578.51 1.59%
VTRS icon
6
Viatris
VTRS
$23.6B
$23.6B $20.55 0.92%
NBIX icon
7
Neurocrine Biosciences
NBIX
$16.7B
$16.7B $165.08 0.14%
ELAN icon
8
Elanco Animal Health
ELAN
$13B
$13B $25.94 1.78%
RDY icon
9
Dr. Reddy's Laboratories
RDY
$12.4B
$12.4B $14.87 1.16%
ALKS icon
10
Alkermes
ALKS
$7.65B
$7.65B $45.50 2.21%
KNSA icon
11
Kiniksa Pharmaceuticals
KNSA
$7.4B
$7.4B $94.24 0.01%
AMRX icon
12
Amneal Pharmaceuticals
AMRX
$7.31B
$7.31B $20.99 1.13%
LNTH icon
13
Lantheus
LNTH
$6.66B
$6.66B $101.77 0.05%
SUPN icon
14
Supernus
SUPN
$6.05B
$6.05B $29.13 1.04%
LQDA icon
15
Liquidia
LQDA
$5.02B
$5.02B $55.70 1.19%
HIMS icon
16
Hims & Hers Health
HIMS
$4.09B
$4.09B $17.44 6.03%
AMLX icon
17
Amylyx Pharmaceuticals
AMLX
$3.5B
$3.5B $27.22 2.09%
BHC icon
18
Bausch Health
BHC
$3.11B
$3.11B $8.32 1.19%
XERS icon
19
Xeris Biopharma Holdings
XERS
$3.03B
$3.03B $16.59 0.66%
HCM icon
20
HUTCHMED
HCM
$2.5B
$2.5B $14.40 2.24%
PBH icon
21
Prestige Consumer Healthcare
PBH
$2.29B
$2.29B $48.40 0.83%
PRGO icon
22
Perrigo
PRGO
$2.24B
$2.24B $16.11 0.43%
RGC icon
23
Regencell Bioscience
RGC
$2.23B
$2.23B $4.49 4.87%
BCRX icon
24
BioCryst Pharmaceuticals
BCRX
$1.92B
$1.92B $7.46 0.13%
ETON icon
25
Eton Pharmaceutcials
ETON
$1.83B
$1.83B $63.28 0.94%

Drug Manufacturers - Specialty & Generic Stocks at a Glance

Specialty and generic drug manufacturers develop branded niche therapies, off-patent generics, and animal-health and cannabis products. Generics compete on price and manufacturing scale, while specialty brands carry pharma-like margins on smaller markets.

There are 79 Drug Manufacturers - Specialty & Generic industry stocks tracked by Wall St. Rank, worth a combined $368B.

The largest by market cap are Takeda Pharmaceutical (TAK) at $69.3B, Teva Pharmaceutical Industries (TEVA) at $49.2B and Haleon (HLN) at $40B.

Among institutional investors, Eton Pharmaceutcials (ETON) drew the most net new fund positions in Q3 2026: 76 funds opened new positions, taking total fund holders up 49 (30%) quarter-over-quarter.

Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q3 2026.